The DOI matches its Crossref record; 317 of the 317 references it cites were found in a registry or an index.
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
Open accessAbstract
Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that are crucial for adaptation of metazoans to limited oxygen availability. Recently, HIF activation and inhibition have emerged as therapeutic targets in various human diseases. Pharmacologically desirable effects of HIF activation include erythropoiesis stimulation, cellular metabolism optimization during hypoxia and adaptive responses during ischaemia and inflammation. By contrast, HIF inhibition has been explored as a therapy for various cancers, retinal neovascularization and pulmonary hypertension. This Review discusses the biochemical mechanisms that control HIF stabilization and the molecular strategies that can be exploited pharmacologically to activate or inhibit HIFs. In addition, we examine medical conditions that benefit from targeting HIFs, the potential side effects of HIF activation or inhibition and future challenges in this field. This Review discusses the mechanisms that regulate stabilization of hypoxia-inducible factors (HIFs), and the pharmacological strategies to activate or inhibit HIFs in diseases such as ischaemia, inflammation, cancer, retinal neovascularization and pulmonary hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Overall, adverse events with HIF-targeted agents are mechanistically informative and context-dependent, supporting patient selection, biomarker-guided monitoring, and agent-specific risk mitigation during prolonged therapy [37].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [37]
The cited source says what the claim attributes to it.
In the citing paper
“The most frequent on-target toxicity with HIF-2 inhibitors (PT2385; belzutifan) is anemia from suppression of renal/hepatic erythropoietin.”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981 · cited 1×
“Similarly, HIFαs are crucial for the induction of tumour growth factors, such as vascular endothelial growth factor (VEGF) 302,303 , via HIF2α in renal cell carcinoma 58 .”
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Ischemia and reperfusion—from mechanism to translation
Eltzschig, H. K., & Eckle, T. D. L. G. (2011) · Nature Medicine · doi:10.1038/nm.2507 · Cited by 3,468
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Self-citation
Research works printed but not linked: 2
- Pelosci, A. LITESPARK-005 trial reveals PFS benefit of belzutifan in advanced RCC. Cancer Network, Home of the Journal ONCOLOGY (23 August 2023).
- Tang, H. et al. Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am. J. Physiol. Lung Cell Mol. Physiol. 314, L256–L275 (2018).
Cited by
Sorted by citations
Items 101–200 of 245
Zhu, J., Yan, J., Zhang, Y., Zhu, X., & Chen, G. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10202-x · Cited by 3
Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α–p300/CBP alliance
Kamel, E. M., Khadrawy, S. M., Allam, A. A., Ahmed, N., Alkhayl, F. F. A., & Lamsabhi, A. M. (2025) · Investigational New Drugs · doi:10.1007/s10637-025-01570-3 · Cited by 4
LPS disrupts erythroid-myeloid balance in zebrafish via Jak2/Stat3-Hif1a signaling
Yu, H., Chen, M.-Y., Zhang, S., Tong, F.-C., Fan-ping, W., Wang, L., Zhang, J.-L., Guo, J.-J., Zhang, B.-Y., Tian, J.-Q., et al. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110874 · Cited by 3
Wu, Y., Zhao, L., Zhang, X., Liu, R., Gao, D., Su, J., Peng, L., Liu, Y., Yan, Y., Xue, Z., et al. (2025) · Fishes · doi:10.3390/fishes10110542 · Cited by 3
Protein–DNA interactions in disease and drug discovery
Mishra, R., & Ahmad, S. (2025) · Chemical Communications · doi:10.1039/d5cc06239j · Cited by 5
Fluorinated polymeric nanoplatform relieves tumor hypoxia and enhances chemo-sonodynamic therapy
Lin, S., Yang, Z., Yu, B., Guanyu, J. I. N., Lv, L., Wang, L., Liu, L., Zhang, S., Xiang, S., Xiang, X., et al. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.03.008 · Cited by 3
Hypoxia: a critical pathophysiological driver in respiratory inflammatory diseases
Zhong, B., Yang, L., Sun, S.-L., Chen, H., & Wang, D. Y. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100023 · Cited by 3
Yang, C., Xu, Z., He, S.-T., Zheng, G.-J., Wang, J., Zang, F., Hu, J.-Q., Wang, Y., Zhang, W.-Y., Gao, C.-F., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01124-z · Cited by 3
Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer
Tang, R., Jin, L., Chen, C., Liao, Y., Li, D., Li, Y., Chen, Y., Liu, Y., Du, Q., Rong, Z., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.05.012 · Cited by 3
Zhou, G., Tao, M., Zhu, J., Li, S., & Zhang, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-04665-2 · Cited by 3
Laboratory medicine and sports
Berković, M. C., Matanović, L., Buljubašić, R., Marijančević, D., Žarak, M., Perović, A., Šimac, B., Marević, S., Biljak, V. R., & Đerek, L. (2024) · Biochemia Medica · doi:10.11613/bm.2024.030501 · Cited by 4
Yu, Z., Ran, G., Chai, J., & Zhang, E. E. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114727 · Cited by 4
Hosny, N., Shen, K., Zhao, Y., Qu, J., Sun, Y. Y., Butler, G., Amend, S. R., Hammarlund, E. U., Gatenby, R. A., Brown, J. S., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112325 · Cited by 3
HIF inhibition: Current strategies and clinical challenges
Więch-Walów, A., Bartoszewska, S., Barton, A., Czechowicz, P., Dudzik, J., Wielockx, B., Collawn, J. F., & Bartoszewski, R. (2026) · Redox biology · doi:10.1016/j.redox.2026.104220 · Cited by 3
“Anemia occurred commonly in early trials and, during prolonged belzutifan therapy, occasionally required transfusion or erythropoiesis-stimulating agents, hence the need for routine hematological monitoring [37,412,421].”
InfluentialCPNE7 promotes colorectal tumorigenesis by interacting with NONO to initiate ZFP42 transcription
Zhao, L., Sun, X., Hou, C., Yang, Y., Wang, P., Xu, Z.-Y., Chen, Z., Zhang, X., Wu, G., Chen, H., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07288-z · Cited by 2
Wang, M., Lu, R., Peng, L., Xu, L., He, S., Guo, T., Lu, M., Luo, Y., & Cui, T.-T. (2025) · Shock · doi:10.1097/shk.0000000000002546 · Cited by 2
Yang, F., Lin, J., Yang, B., Hu, A., Cui, K., Wu, P., Kong, H., Liu, C., Xu, K., Lü, X., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.9.47 · Cited by 2
Zhang, Y., Zhang, Z., Chi, Y., Yun, H., Zhang, Q., Cao, W., Bai, H., Wei, B., Liu, H., Li, J., et al. (2025) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004767 · Cited by 2
HIF-1–mediated ISG20 expression promotes breast cancer stemness and immune evasion
Yang, Y., Zuo, Q., Ramu, V., Talwar, V., Lv, Y., Chen, C. O., Drehmer, D., Huang, T., Salman, S., Dordai, D. I., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250777 · Cited by 2
Zhang, W., Yin, H., Wang, C., Ma, X., Miao, D., Li, G., Chen, W., Hou, Z., Gao, X., Zhang, Y., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118940 · Cited by 2
Wo, Y., Zhong, R., Wang, L. C., Jianhua, H., Schroyen, M., O'Reilly, S., Chen, L., & Zhang, H. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100185 · Cited by 2
Karaman, İ., Erdem, D., & Çetin, B. (2026) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-025-04861-x · Cited by 2
Yu, Y., Zhang, Y., & Yang, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1707886 · Cited by 3
Macrophage Metabolic Reprogramming-Related Osteoimmunity in Osteoporosis
Zhou, K., Wang, Z., & Zhang, M. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01477-y · Cited by 4
A mechanistic computational model of the HIF signaling pathway in endothelial cells
Oliveira, R. H. D. M., Pathak, A. P., & Popel, A. S. (2026) · iScience · doi:10.1016/j.isci.2026.116195 · Cited by 2
Recent advance of hypoxia-inducible factor prolyl hydroxylases inhibitors for anemia therapy
Wang, D., Zhao, W., Wang, Y., Ni, S., Feng, C., & Yao, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117907 · Cited by 2
Metabolic Reprogramming in Kidney Cancer: Implications for Therapy
Edo, E. T. (2025) · annals of urologic oncology · doi:10.32948/auo.2025.06.02 · Cited by 2
Zhang, Y., Jin, P., Deng-zhou, G., & Bian, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31265 · Cited by 2
Yan, J., Zhang, Z., Ge, Y., Chen, J., Xu, H., Gao, R., Huang, M., Xiao, C., Zhang, H., Gao, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4627119/v1 · Cited by 2
Liu, Z., Hou, J., Tian, M., Zhang, Y., Huang, D., Zhao, N., Ma, Y., & Cui, S. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111751 · Cited by 1
ICG/MnO2-HFn-mPEG-DSPE-Lip enhances the anticancer activity of ICG phototherapy
Ma, D., Lu, H., Zhang, H. F., Liao, A.-R., Peng, Q., & Yang, M. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04494-9 · Cited by 1
Trinh, V. T., Fischer, S., Zhang, L., Geisler, H., Pardo, B., Liefke, R., Abendroth, F., & Vázquez, O. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202511183 · Cited by 1
The role of USP36 in ribosome biogenesis and other pathophysiological processes
Shao, L., Guo, M., Kou, Q., Guo, Y., Li, X., & Li, F. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1650908 · Cited by 1
Chen, M., Wang, K., Zhang, H., Tang, B., Qu, Y., Luan, J., Luo, M., Li, H., Luo, C., Luo, Z., et al. (2025) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.126845 · Cited by 1
HIF-1α in glioblastoma multiforme cells: Mechanisms involving the Wnt/β-catenin signaling pathway
Shen, J. F., Song, Y., Wang, G., Zhu, J., & Yu, G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149919 · Cited by 1
Liu, G., Hu, P., Dong, Y., Xu, Y., Yang, Z., Qi, Z., & Su, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1600903 · Cited by 1
Du, Y., Zuo, W., Shao, Y., Ji, Y., Su, B., Liang, S., Wang, D., Li, B., Feng, Y., Gong, L., et al. (2025) · Journal of Virus Eradication · doi:10.1016/j.jve.2025.100612 · Cited by 1
Cutting-edge approaches to diagnosing and treating limb ischemia in peripheral arterial disease
Okoro, G., Owunnah, F. K., Applegate, C. C., Nelappana, M. B., Dobrucki, I. T., & Dobrucki, L. W. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ae16f1 · Cited by 1
Tang, K. L., Cheng, Y., Gong, J., & Li, Y. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114868 · Cited by 1
Hypoxic microenvironment and pulmonary hypertension
Mu, T., Guo, B., Xiang, C., Liu, Z., Ren, J., Liu, M., & Zhao, P. (2025) · Respiratory Research · doi:10.1186/s12931-025-03448-7 · Cited by 1
Zeng, Y., Chen, D., Li, K., Kang, X., Chang, P., Lu, Y., Ma, J., Wang, W., Yang, Q., Tang, L., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03960-4 · Cited by 1
Panosetti, M., Vecchio, D., Maucort, C., Mongiardini, V., Giorgio, A. D., Grimaldi, B., & Duca, M. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02728 · Cited by 1
Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis
Lin, Y., Du, Y. F., Shu, Q., Su, W., Peng, H., & Wang, X. (2026) · The FASEB Journal · doi:10.1096/fj.202503954rr · Cited by 1
SENP1 drives de novo cholesterogenesis via disrupting SUMOylation-mediated SREBP2-FBXW7 interaction
Yang, C., Wang, Q., Han, B., & Shangguan, X. (2026) · Cancer & Metabolism · doi:10.1186/s40170-026-00434-5 · Cited by 1
Fava, V. M., Dallmann-Sauer, M., Orlova, M., Correa-Macedo, W., Olivenstein, R., Costiniuk, C. T., Routy, J., Barreiro, L. B., & Schurr, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805936 · Cited by 1
Progress and challenges in the development of advanced pancreatic cancer organoids
Detert, K., Piotrowsky, A., Marongiu, L., Leischner, C., Lauer, U. M., Venturelli, S., & Burkard, M. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03717-3 · Cited by 2
Kong, L., Liang, J., Liu, D., Jia, S., Gu, H., He, Y., Luo, W., Cao, S., Dong, Y., Yang, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72988-3 · Cited by 1
Renal Cell Carcinoma: Histopathology, Molecular Features, and the Emerging Role of Organoid Models
Coppola, A. K., Shahini, A., Mehrjoo, Z., Tarikere, S., Tanguay, S., & Riazalhosseini, Y. (2026) · Gene · doi:10.1016/j.gene.2026.150216 · Cited by 1
Nahar, J. S., Lim, S. S., & Lee, D. (2026) · Aging advances. · doi:10.4103/agingadv.agingadv-d-26-00005 · Cited by 1
Zhu, H., Wang, R., & Zhou, M. (2026) · Biomaterials Science · doi:10.1039/d6bm00677a · Cited by 1
Artificial intelligence derived virtual oncology
Lyu, C., Yao, D., Yin, F., Liu, Z., Liu, B., Ma, H., & Sun, T. (2026) · The Innovation Oncology · doi:10.59717/j.xinn-oncol.2026.100028 · Cited by 1
Liu, S., Xu, J., Zhang, H., Tang, Y., Han, X., Xiong, W., Fan, L., Su, C., Sui, Z., & Zhao, W. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03103-8 · Cited by 1
Gonzales, G., Malka, R. E., Marinelli, L. M., Lee, C. M., Cook, S., Miar, S., Dion, G. R., & Guda, T. (2024) · Respiratory Research · doi:10.1186/s12931-024-02973-1 · Cited by 1
Hypoxia and collagen deposition in the kidneys infected with Acanthamoeba sp.
Kot, K., Grabowska, M., Tarnowski, M., Kupnicka, P., Tomasiak, P., Kosik-Bogacka, D. I., & Łanocha-Arendarczyk, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-79848-4 · Cited by 1
Feeding cancer to death - a triad of aromatic acids reduces tumor growth
Xavier, A., & D̵ikić, I. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01372-9 · Cited by 1
Regulation of Epithelial HIF by Probiotic Escherichia coliPreprint
Dowdell, A. S., Roer, R. L., Bhagavatula, G., Cartwright, I. M., Cohen, R. H., Countess, J. A., Koch, S. D., Lee, J. S., Steiner, C. A., Thompson, N. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.14.654147 · Cited by 1
Cheng, Y., Tang, K. L., Gong, J., & Li, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4860804/v1
Li, Z., Yin, B., Xu, Y., Wang, C., Li, X., Lu, S., Ke, S., Qian, B., Yu, H., Bai, M., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000567
Spatiotemporal dynamics of CD73 in mouse retina under physiological conditionsPreprint
Ishii, R., Sakurai, K., Hosomi, N., Fleischmann, B. K., Mizuno, S., Kimura, K., & Yanagisawa, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.25.655881
Sats, N. V., Сурин, В. Л., Abramova, T. V., Sadovskaya, A. V., Петинати, Н. А., Михайлович, К. Н., Никифорова, К. А., Дризе, Н. И., Karaseva, L., Pokrovskaya, O. S., et al. (2025) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2025.103859
Trinh, V. T., Fischer, S., Zhang, L., Geisler, H., Pardo, B., Liefke, R., Abendroth, F., & Vázquez, O. (2025) · Angewandte Chemie · doi:10.1002/ange.202511183
A microfluidic model to recapitulate pH and oxygen gradients in solid tumorsPreprint
Li, Y., Santos, L. D., Charan, M. R., Auxillos, J., Sandelin, A., Pedersen, S. F., & Marie, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.05.663284
Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91
Song, L., Han, J., Wang, R., Cao, S., Tai, Y., Wang, X., Zheng, Y., Jin, S., Xing, Y., Zuo, H. X., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1607264
Zhang, C., Liu, S., Cao, Y., Zhang, W., He, Y., Tu, W., Xue, W., Gao, D., & Zhang, X. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.138999
Anticancer Therapy Against Glioma by Peptide-Based Therapeutics
Mitra, S., Das, S., Mukherjee, S., Karati, D., & Meur, S. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10755-6
Canus, L., Jacquemin, C., Orch, W. E., Ogire, E., Ferren, M., Moissonnier, E., Lalande, A., Bourgeais, A., Ducret, G., Bouget, J., et al. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2563067
Peng, Q., Cai, Y.-T., Ding, Q., Qian, X.-Y., Xu, C., Zhou, H., Chen, H., Li, H., & Wang, W. (2025) · Medical Oncology · doi:10.1007/s12032-025-03049-w
Yun, W., Li, Y., Ge, Y., Zhang, X., Liu, H., Chen, W., & Li, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1639922
Lu, Y., Yan, Z., Lyu, X., Zhang, S., & Zhao, Y. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33885-4.00043-3
Punia, R., & Goel, G. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01556
EPAS1 regulates host antibacterial defense in response to bacterial quorum sensingPreprint
Li, H., Kong, X., Cui, B., Li, X., Li, X., Wang, M., Wang, L.-E., Chen, X., Qian, W., Zhang, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681351
Effects and Mechanism of 2′-AMP on Renal Vascular Resistance
Jackson, E. K., Cheng, D., Gillespie, D. G., Mi, Z., Tofovic, S. P., Menshikova, E. V., Ritov, V. B., & Kim‐Campbell, N. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000954
Gonzales, G., Malka, R. E., Marinelli, L. M., Lee, C. M., Cook, S., Miar, S., Dion, G. R., & Guda, T. (2024) · Figshare · doi:10.6084/m9.figshare.27129494
SUMO protease Pira induces autophagy-related cell death during Drosophila development
Gan, T., Su, Q., Zhang, Y., Zhao, L., & Su, Y. (2025) · Genetics · doi:10.1093/genetics/iyaf277
Ambattu, A., Rahmathullah, S., Raghunath, M., Prabhu, R. S., & Vasudevan, S. (2025) · Indian Journal of Nephrology · doi:10.25259/ijn_103_2025
Identification of novel HIF2α inhibitors: a structure‐based virtual screening approach
Zhou, S., Yin, S., Yang, S., Wang, Y., & Feng, P. (2026) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2606435
Zhang, Y., Yi-da, P., Zheng, W.-Y., Wen, Q.-Q., Zhu, M., Li, H.-Y., Liang, W.-Q., Zhu, Z.-Y., Liu, B.-C., Yuan, X.-R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.14.699586
Self-citationNanoscale magnesium hydride alleviates hypoxia-induced myelination deficits in zebrafish
Li, J., Chen, Q., Li, Z., Xu, D., He, C., & Liu, P. (2026) · Medical Gas Research · doi:10.4103/mgr.medgasres-d-25-00104
Cobalt Chloride Protects Against Intestinal Irradiation‐Induced Injury by Activating the HIF ‐2α
Zhao, J., Liu, R., Shou, Z., Fang, L., Wang, Y., Feng, Z., Cai, S., Yu, R., Cheng, Y., Du, J., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202501410r · Cited by 1
Li, Z., Huang, W., Yao, Z., Wang, J., Xiao, W., Guo, Q., Chen, C., Xie, T., Yang, Z., Liu, Q., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115216
Guo, J., Huang, J., Wang, Y., Sun, J., Liu, S., Deng, C., LÜ, J., & Zhong, Z. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.03.005
Liang, C., Guo, J., Qiao, W., & Lee, S. J. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.02.020 · Cited by 4
Kan, M. U., Kan, H., Alsancak, Y., & Baylan, F. A. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05744-6
Wu, R., Ling, Y., He, Y., Yao, L., Shi, Q., Shen, W., Li, X., Liu, Y., & Li, J. (2026) · PeerJ · doi:10.7717/peerj.20704
Characterizing and targeting the microenviromental changes in PIK3CA related overgrowth syndromes
Galasso, I. (2024) · theses.fr (ABES) · doi:10.70675/b81c167azcc23z4977z90f0z0ff71e3da7c4
Ye, Y., Long, J., Hu, P., Shen, J., Gong, J., Lu, X., & Long, D. (2026) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1177/10807683261441054
Albatsh, M. (2026) · Die Pharmazie · doi:10.31083/pharmazie51801
2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation
Thamim, M., Dhabal, D., Balamurali, M. M., & Thirumoorthy, K. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1791517
Transcription Factors in the Pathogenesis of Schizophrenia
Helaly, A. M., & Al‐Emam, A. (2026) · Life · doi:10.3390/life16050773
Recent Advances in Nanomedicine for Targeted Phototherapy in Head and Neck Cancer
Liu, H., Chen, L., Li, W., Wu, L., Xia, Z., Wu, Y., Huang, Y., Gu, S., Zhang, J., & Shen, Z. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s596902
Wang, T., Peng, X., Yang, P., Ji, M., Miao, Y., Zhang, J., Liu, W., Zhu, Y., Tang, M., & Sun, J. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152621
Metabolic host-microbe crosstalk in stabilization of epithelial HIF
Dowdell, A. S., Roer, R. L., Bhagavatula, G., Cartwright, I. M., Cohen, R. H., Countess, J. A., Koch, S. D., Lee, J. S., Liu, L., Steiner, C. A., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02431-8 · Cited by 1
Li, J., Du, F., Ji, Y., Wang, H., Zhu, D., Zhou, W., Chen, N., Dai, L., Fang, C., Liu, Y., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102265
Hypothermic Treatment Alleviates Myocardial Hypertrophy in bmp10-/- Zebrafish
Li, F., Hu, R., Yang, B., Jiang, S., Chen, L., & Chen, Z. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl49658
Tian, S., Wang, J., Yu, Y., Liu, Y. G., Liu, Y. G., Li, J., Shang, Y., Zhao, Y., Zhang, Y., Fang, Y., et al. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101170
Yang, Q., Ding, H., Chen, L., Sun, S., Chen, C., Ren, M., Huang, F., Sun, Y., Zhang, J., Zhang, W., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03853-2
HIFs: The central drivers of tumors and their role as molecular switches in targeted therapy?
Peng, Y., Che, Y., Zhao, Y., Wang, Z., Pei, Z., Hu, Y., Yin, Y., Pan, X., Hu, X., Wei, M., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.040
Feeding the invaders: how metabolic imbalance shapes infection and biofilm development
Mahajan, S., Macdowell, S., Mitchem, C. F., Alexander, E., & Wozniak, D. J. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuag029
Li, J., Yang, Q., Pang, P., Liu, Y., Liu, X., Zhong, W., Zhang, R., Sun, W., He, Y., & Ye, Q. (2026) · Autophagy · doi:10.1080/15548627.2026.2694664
Neuronal Guidance Proteins in the Fundamental Biology of Inflammation Resolution
Mirakaj, V. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_349
Metadata
- Authors
- Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P., & Eltzschig, H. K.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Central South University (CN)
- Khalifa University of Science and Technology (AE)
- Outcomes Research Consortium (US)
- Corresponding author
- Yuan, Xiaoyi
- Eltzschig, Holger K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2023-12-20
- Volume
- 23
- Issue
- 3
- Pages
- 175-200
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC12337356
- OpenAlex
- W4390038502
- Cited by
- 245
- References
- 317
- Citations by year
- 2026: 100 · 2025: 96 · 2024: 48 · 2023: 1
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- green
- pure.au.dk
- Licence
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Lirias (submittedVersion, other-oa)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- Funders
- U.S. Department of Defense (W81XWH2110032)
- Akebia Therapeutics
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL154720, R01HL165748, R01HL169519, R01HL155950)
- National Institute of General Medical Sciences (T32GM135118)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK122796)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- hypoxia-inducible factor, HIF stabilization, HIF activation, HIF inhibition, oxygen sensing, erythropoiesis, ischemia, inflammation, cancer therapy, retinal neovascularization, pulmonary hypertension, pharmacological targeting, adverse effects
- MeSH terms
- Hypoxia, Humans, Neoplasms, Oxygen, Transcription Factors, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
